Publicacións nas que colabora con Juan Suárez Pérez (8)

2024

  1. Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 5, pp. 1571-1583

2022

  1. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

2020

  1. Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury

    British Journal of Pharmacology, Vol. 177, Núm. 14, pp. 3309-3326

  2. Impact of intermittent voluntary ethanol consumption during adolescence on the expression of endocannabinoid system and neuroinflammatory mediators

    European Neuropsychopharmacology, Vol. 33, pp. 126-138

  3. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants

    Neuropharmacology, Vol. 149, pp. 212-220

2017

  1. Acetaminophen-induced liver injury alters the Acyl ethanolamine-based anti-inflammatory signaling system in liver

    Frontiers in Pharmacology, Vol. 8, Núm. OCT

2015

  1. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity

    Addiction Biology, Vol. 20, Núm. 4, pp. 756-772